Virginia Retirement Systems Et Al Vericel Corp Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 27, 2020
SELL
$13.77 - $19.2 $205,173 - $286,080
-14,900 Closed
0 $0
Q3 2019

Oct 22, 2019
BUY
$14.93 - $19.83 $14,930 - $19,830
1,000 Added 7.19%
14,900 $226,000
Q2 2019

Jul 26, 2019
BUY
$15.01 - $18.89 $19,513 - $24,557
1,300 Added 10.32%
13,900 $263,000
Q1 2019

Apr 25, 2019
BUY
$16.23 - $20.29 $204,498 - $255,654
12,600 New
12,600 $221,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.8M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.48B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email